DiaMedica Therapeutics (DMAC) Enterprise Value Growth (1y) (2018 - 2026)
DiaMedica Therapeutics (DMAC) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,740.48% |
| Dec 31, 2025 | -35.66% |
| Sep 30, 2025 | -10.20% |
| Jun 30, 2025 | 92.03% |
| Mar 31, 2025 | 94.00% |
| Dec 31, 2024 | 16.54% |
| Sep 30, 2024 | -8.03% |
| Jun 30, 2024 | -33.91% |
| Mar 31, 2024 | -62.33% |
| Dec 31, 2023 | -57.89% |
| Sep 30, 2023 | -1,571.40% |
| Jun 30, 2023 | -5.01% |
| Mar 31, 2023 | -814.04% |
| Dec 31, 2022 | 25.74% |
| Sep 30, 2022 | 94.22% |
| Jun 30, 2022 | -80.53% |
| Mar 31, 2022 | 86.60% |
| Dec 31, 2021 | -508.06% |
| Sep 30, 2021 | -390.44% |
| Jun 30, 2021 | -80.48% |